
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Precision glycocalyx editing as a strategy for cancer immunotherapy
Han Xiao, Elliot C. Woods, Petar Vukojicic, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 37, pp. 10304-10309
Open Access | Times Cited: 366
Han Xiao, Elliot C. Woods, Petar Vukojicic, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 37, pp. 10304-10309
Open Access | Times Cited: 366
Showing 1-25 of 366 citing articles:
Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan, Bryant C. Yung, Peng Huang, et al.
Chemical Reviews (2017) Vol. 117, Iss. 22, pp. 13566-13638
Closed Access | Times Cited: 1591
Wenpei Fan, Bryant C. Yung, Peng Huang, et al.
Chemical Reviews (2017) Vol. 117, Iss. 22, pp. 13566-13638
Closed Access | Times Cited: 1591
Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors
Zheyu Shen, Ting Liu, Yan Li, et al.
ACS Nano (2018) Vol. 12, Iss. 11, pp. 11355-11365
Closed Access | Times Cited: 546
Zheyu Shen, Ting Liu, Yan Li, et al.
ACS Nano (2018) Vol. 12, Iss. 11, pp. 11355-11365
Closed Access | Times Cited: 546
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
Chia‐Wei Li, Seung-Oe Lim, Ezra M. Chung, et al.
Cancer Cell (2018) Vol. 33, Iss. 2, pp. 187-201.e10
Open Access | Times Cited: 471
Chia‐Wei Li, Seung-Oe Lim, Ezra M. Chung, et al.
Cancer Cell (2018) Vol. 33, Iss. 2, pp. 187-201.e10
Open Access | Times Cited: 471
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Stefan Mereiter, Meritxell Balmaña, Diana Campos, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 6-16
Open Access | Times Cited: 427
Stefan Mereiter, Meritxell Balmaña, Diana Campos, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 6-16
Open Access | Times Cited: 427
Small RNAs are modified with N-glycans and displayed on the surface of living cells
Ryan A. Flynn, Kayvon Pedram, Stacy A. Malaker, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3109-3124.e22
Open Access | Times Cited: 400
Ryan A. Flynn, Kayvon Pedram, Stacy A. Malaker, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3109-3124.e22
Open Access | Times Cited: 400
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
John V. Pluvinage, Michael S. Haney, Benjamin Smith, et al.
Nature (2019) Vol. 568, Iss. 7751, pp. 187-192
Open Access | Times Cited: 368
John V. Pluvinage, Michael S. Haney, Benjamin Smith, et al.
Nature (2019) Vol. 568, Iss. 7751, pp. 187-192
Open Access | Times Cited: 368
The tumour glyco-code as a novel immune checkpoint for immunotherapy
Ernesto Rodríguez, Sjoerd Schetters, Yvette van Kooyk
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 204-211
Closed Access | Times Cited: 363
Ernesto Rodríguez, Sjoerd Schetters, Yvette van Kooyk
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 204-211
Closed Access | Times Cited: 363
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Benjamin Smith, Carolyn R. Bertozzi
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 3, pp. 217-243
Open Access | Times Cited: 352
Benjamin Smith, Carolyn R. Bertozzi
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 3, pp. 217-243
Open Access | Times Cited: 352
Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan, James C. Paulson
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 365-395
Open Access | Times Cited: 334
Shiteng Duan, James C. Paulson
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 365-395
Open Access | Times Cited: 334
Brief update on endocytosis of nanomedicines
Siddharth Patel, Jeonghwan Kim, Marco Herrera-Barrera, et al.
Advanced Drug Delivery Reviews (2019) Vol. 144, pp. 90-111
Open Access | Times Cited: 317
Siddharth Patel, Jeonghwan Kim, Marco Herrera-Barrera, et al.
Advanced Drug Delivery Reviews (2019) Vol. 144, pp. 90-111
Open Access | Times Cited: 317
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 277
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 277
Targeted glycan degradation potentiates the anticancer immune response in vivo
Melissa A. Gray, Michal A. Stanczak, Natália Rodrigues Mantuano, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 12, pp. 1376-1384
Open Access | Times Cited: 261
Melissa A. Gray, Michal A. Stanczak, Natália Rodrigues Mantuano, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 12, pp. 1376-1384
Open Access | Times Cited: 261
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
Stacy A. Malaker, Kayvon Pedram, Michael J. Ferracane, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 15, pp. 7278-7287
Open Access | Times Cited: 241
Stacy A. Malaker, Kayvon Pedram, Michael J. Ferracane, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 15, pp. 7278-7287
Open Access | Times Cited: 241
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Matthew R. Kudelka, Sean R. Stowell, Richard D. Cummings, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 597-617
Open Access | Times Cited: 236
Matthew R. Kudelka, Sean R. Stowell, Richard D. Cummings, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 597-617
Open Access | Times Cited: 236
Engineering and physical sciences in oncology: challenges and opportunities
Michael J. Mitchell, Rakesh K. Jain, Róbert Langer
Nature reviews. Cancer (2017) Vol. 17, Iss. 11, pp. 659-675
Open Access | Times Cited: 234
Michael J. Mitchell, Rakesh K. Jain, Róbert Langer
Nature reviews. Cancer (2017) Vol. 17, Iss. 11, pp. 659-675
Open Access | Times Cited: 234
An Overview of Drug Delivery Systems
Kewal K. Jain
Methods in molecular biology (2019), pp. 1-54
Closed Access | Times Cited: 232
Kewal K. Jain
Methods in molecular biology (2019), pp. 1-54
Closed Access | Times Cited: 232
Insights into the role of sialylation in cancer progression and metastasis
Christopher Dobie, Danielle Skropeta
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 76-90
Open Access | Times Cited: 232
Christopher Dobie, Danielle Skropeta
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 76-90
Open Access | Times Cited: 232
Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity
Christian Büll, Thomas J. Boltje, Natasja Balneger, et al.
Cancer Research (2018) Vol. 78, Iss. 13, pp. 3574-3588
Open Access | Times Cited: 220
Christian Büll, Thomas J. Boltje, Natasja Balneger, et al.
Cancer Research (2018) Vol. 78, Iss. 13, pp. 3574-3588
Open Access | Times Cited: 220
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Joyce Lübbers, Ernesto Rodríguez, Yvette van Kooyk
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 220
Joyce Lübbers, Ernesto Rodríguez, Yvette van Kooyk
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 220
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Heinz Laübli, Lubor Borsig
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 211
Heinz Laübli, Lubor Borsig
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 211
Targeting Glycosylation: A New Road for Cancer Drug Discovery
Ana Filipa Costa, Diana Campos, Celso A. Reis, et al.
Trends in cancer (2020) Vol. 6, Iss. 9, pp. 757-766
Open Access | Times Cited: 208
Ana Filipa Costa, Diana Campos, Celso A. Reis, et al.
Trends in cancer (2020) Vol. 6, Iss. 9, pp. 757-766
Open Access | Times Cited: 208
Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
Emily Rodrigues, Matthew S. Macauley
Cancers (2018) Vol. 10, Iss. 6, pp. 207-207
Open Access | Times Cited: 197
Emily Rodrigues, Matthew S. Macauley
Cancers (2018) Vol. 10, Iss. 6, pp. 207-207
Open Access | Times Cited: 197
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
Ernesto Rodríguez, Kelly Boelaars, Kari Brown, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 197
Ernesto Rodríguez, Kelly Boelaars, Kari Brown, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 197
The Emerging Role of the Mammalian Glycocalyx in Functional Membrane Organization and Immune System Regulation
Leonhard Möckl
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 192
Leonhard Möckl
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 192
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease
Jose D. Pagan, Maya Kitaoka, Robert M. Anthony
Cell (2017) Vol. 172, Iss. 3, pp. 564-577.e13
Open Access | Times Cited: 185
Jose D. Pagan, Maya Kitaoka, Robert M. Anthony
Cell (2017) Vol. 172, Iss. 3, pp. 564-577.e13
Open Access | Times Cited: 185